Clinical Trial Update: Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel and gemcitabine in elderly patients with untreated metastatic pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Carcinoma Metastatic

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Asociación de Oncología Médica del Hospital de Cruces | Conditions: Pancreatic Carcinoma Metastatic | Phase 2 | Status: COMPLETED